News
Indigo Appoints Dr. Arun Venkatasubramanian as Chief Technology Officer
Arun is an award-winning engineer who brings over 15 years’ experience in leading the design and development of transformational technology within the medical, consumer, and military sectors BELGIUM – Ghent, 15 May 2023 – Indigo Diabetes N.V. (‘Indigo’ or the...
Indigo Diabetes completion of VLAIO Hephaestus Research Project
Indigo Diabetes nv. has completed the Hephaestus Research Project. In September 2021, Indigo received a €3 million Hephaestus grant from VLAIO, the Flanders organisation for Innovation & Entrepreneurship, to conduct research into the high-volume production of...
Indigo Diabetes CMM® Sensor to be featured in Presentations at ATTD 2023
BELGIUM – Ghent, 21 February 2023: Indigo Diabetes N.V. (‘Indigo’ or the ‘Company’), a pioneering developer of Continuous Metabolite Monitoring (CMM®) devices utilising proprietary nanophotonics technology, today announces that that an abstract featuring its CMM®...
Indigo Diabetes Business Update
SHINE clinical trial enrolment progressing well following positive results from the GLOW early feasibility trial Several key senior appointments made in Europe and the US, reflecting the growth and evolution from an early stage to a development stage...